MetLife Investment Management’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-119,198
Closed -$143K 3020
2023
Q2
$143K Buy
119,198
+34,112
+40% +$41.9K ﹤0.01% 2477
2023
Q1
$129K Sell
85,086
-32,875
-28% -$124K ﹤0.01% 2451
2022
Q4
$445K Hold
117,961
﹤0.01% 1712
2022
Q3
$587K Hold
117,961
﹤0.01% 1520
2022
Q2
$547K Buy
+117,961
New +$721K ﹤0.01% 1587

Other funds holding PTRA

MetLife Investment Management's PTRA Position: Q3 2023 in Review

MetLife Investment Management sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 119,198 shares — an estimated $143K sold.

MetLife Investment Management first reported a position in PTRA in Q2 2022 and held it in 5 quarters. The position peaked at $587K in Q3 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • MetLife Investment Management reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • MetLife Investment Management sold 119,198 Proterra Inc. Common Stock shares in Q3 2023, an estimated $143K.
  • MetLife Investment Management first reported a position in Proterra Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • MetLife Investment Management's Proterra Inc. Common Stock position peaked at $587K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on MetLife Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.